Astellas Pharma US Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Astellas Pharma US Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014029
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a drug company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules and injections. It provides amphotericin B liposome for injection, isavuconazonium sulfate, micafungin sodium for injection, erlotinib tablets, enzalutamide capsules, mirabegron extended-release tablets and solifenacin succinate tablets. Astellas Pharma also provides clinical trials and pharmaceutical products in different therapeutic areas. The company’s services include research and development; patient assistance program and medical safety consulting services. Its products are used in therapeutic areas including cardiology, dermatology, immunology, infectious disease, neuroscience, oncology and urology. Astellas Pharma is headquartered in Northbrook, Illinois, the US.

Astellas Pharma US Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Astellas Pharma US Enters Into Distribution Agreement With Tecnofarma For Enzalutamide 10
Nagasaki University Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 12
Asset Transactions 13
Cumberland Pharma Acquires Vaprisol From Astellas Pharma 13
Astellas Pharma US Inc – Key Competitors 15
Astellas Pharma US Inc – Key Employees 16
Astellas Pharma US Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Jun 23, 2016: Astellas Launches New Latin America Affiliate in Colombia 18
Corporate Communications 19
May 16, 2017: Astellas Announces Key Leadership Promotions in its Commercial Organization 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Key Facts 2
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astellas Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astellas Pharma US Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Astellas Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astellas Pharma US Enters Into Distribution Agreement With Tecnofarma For Enzalutamide 10
Nagasaki University Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 12
Cumberland Pharma Acquires Vaprisol From Astellas Pharma 13
Astellas Pharma US Inc, Key Competitors 15
Astellas Pharma US Inc, Key Employees 16

★海外企業調査レポート[Astellas Pharma US Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務分析
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Sectra AB (SECT B):医療機器:M&Aディール及び事業提携情報
    Summary Sectra AB (Sectra) develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information te …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務情報
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • RussNeft Oil Co (RNFT):石油・ガス:M&Aディール及び事業提携情報
    Summary RussNeft Oil Company (RussNeft) is an oil and gas company that produces, refines and distributes crude oil, gas and petroleum products. The company operates through its business divisions such as geologic exploration and reserves, production, marketing, research center, transport and gas pro …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • Visa Inc:企業の戦略・SWOT・財務分析
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Canadian National Railway Co:戦略・SWOT・企業財務分析
    Canadian National Railway Co - Strategy, SWOT and Corporate Finance Report Summary Canadian National Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Barrick Gold Corporation:企業のM&A・事業提携・投資動向
    Barrick Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barrick Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Ferguson Enterprises LLC:企業の戦略的SWOT分析
    Ferguson Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Zynerba Pharmaceuticals Inc (ZYNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Netcare Ltd (NTC):企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Activision Blizzard Inc (ATVI):企業の財務・戦略的SWOT分析
    Activision Blizzard Inc (ATVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Scoular Company:戦略・SWOT・企業財務分析
    The Scoular Company - Strategy, SWOT and Corporate Finance Report Summary The Scoular Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆